leonurine has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, ZY; Shi, XR; Wu, TT; Zhu, K; Zhu, YZ | 1 |
| Hong, ZY; Wang, ZJ; Yu, SS; Zhu, YZ | 1 |
2 other study(ies) available for leonurine and Cognition Disorders
| Article | Year |
|---|---|
SCM-198 inhibits microglial overactivation and attenuates Aβ(1-40)-induced cognitive impairments in rats via JNK and NF-кB pathways.
Topics: Amyloid beta-Peptides; Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Cerebral Cortex; Coculture Techniques; Cognition Disorders; Cytokines; Gallic Acid; L-Lactate Dehydrogenase; Male; MAP Kinase Kinase 4; Maze Learning; Microglia; Neurons; Neuroprotective Agents; NF-kappa B; Peptide Fragments; Rats; Rats, Sprague-Dawley; Signal Transduction | 2014 |
SCM-198 Ameliorates Cognitive Deficits, Promotes Neuronal Survival and Enhances CREB/BDNF/TrkB Signaling without Affecting Aβ Burden in AβPP/PS1 Mice.
Topics: Amyloid beta-Peptides; Animals; Brain; Brain-Derived Neurotrophic Factor; Cell Survival; Cells, Cultured; Cognition Disorders; Cyclic AMP Response Element-Binding Protein; Gallic Acid; Humans; Male; Maze Learning; Membrane Glycoproteins; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Protein-Tyrosine Kinases; Signal Transduction | 2015 |